7th International conference on the Environmental Dimension of Antimicrobial Resistance (EDAR7)

  26 May 2024 - 31 May 2024

   Montreal, Canada

conference-img

7th International conference on the Environmental Dimension of Antimicrobial Resistance (EDAR7)

26 May 2024

 - 

31 May 2024

Montreal, Canada



Explore the nexus of environmental, agricultural, and human health at our conference on antimicrobial resistance (AMR). Delve into innovative approaches, economic considerations, and policy implications amidst global crises, fostering interdisciplinary dialogue for effective AMR mitigation.

Discover the latest in AMR management: from groundbreaking research to interdisciplinary strategies, our conference offers unparalleled learning opportunities for tackling evolving challenges.

International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026


International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

2.

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

3.

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

4.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

5.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot